Litigation Details for Amarin Pharma, Inc. v. Roxane Laboratories, Inc. (N.D. Ohio 2014)
✉ Email this page to a colleague
Amarin Pharma, Inc. v. Roxane Laboratories, Inc. (N.D. Ohio 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-25 |
| Court | District Court, N.D. Ohio | Date Terminated | 2014-05-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Christopher A. Boyko |
| Jury Demand | None | Referred To | |
| Patents | 8,293,728; 8,318,715; 8,357,677; 8,367,652; 8,377,920; 8,399,446; 8,415,335; 8,426,399; 8,431,560; 8,440,650; 8,501,225; 8,518,929; 8,524,698; 8,546,372; 8,551,521; 8,617,594 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Amarin Pharma, Inc. v. Roxane Laboratories, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Amarin Pharma, Inc. v. Roxane Laboratories, Inc. (N.D. Ohio 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-04-25 | 1 | of U.S. Patent No. 8,293,728 (“the ‘728 Patent”), U.S. Patent No. 8,318,715 (“the ‘715 Patent”), U.S. …paragraphs l to 25 above. 27. United States Patent No. 8,293,728, entitled “METHODS OF TREATING HYPERTRIGLYCERIDEMIA…. Patent No. 8,357,677 (“the ‘677 Patent”), U.S. Patent No. 8,367,652 (“the ‘652 Patent”), U.S. Patent…8,377,920 (“the ‘920 Patent”), U.S. Patent No. 8,399,446 (“the ‘446 Patent”), U.S. Patent No. 8,415,335 (“…(“the ‘3 35 Patent”), U.S. Patent No. 8,426,399 (“the ‘399 Patent”), U.S. Patent NO. 8,431,560 (“the | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
